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Summary Six human melanoma xenograft lines grown s.c. in BALB/c-nu/nu mice weresubjected to 3'P-
nuclear magnetic resonance ("P-NMR) spectroscopy in vivo. The following resonances were detected: phos-
phomonoesters (PME), inorganic phosphate (Pi), phosphodiesters (PDE), phosphocreatine (PCr) and
nucleoside triphosphate y, a and P (NTPy, a and P). The main purpose of the work was to search for possible
relationships between 3'P-NMR resonance ratios and tumour pH on the one hand and blood supply per viable
tumour cell on the other. The latter parameter was measured by using the 'Rb uptake method.
Tumour bioenergetic status [the (PCr +NTPP)/Pi resonance ratio], tumour pH and blood supply per viable
tumour cell decreased with increasing tumour volume for five of the six xenograft lines. The decrease in
tumour bioenergetic status was due to a decrease in the (PCr + NTPP)/total resonance ratio as well as an
increase in the Pi/total resonance ratio. The decrease in the (PCr + NTPP)/total resonance ratio was mainly a
consequence of a decrease in the PCr/total resonance ratio for two lines and mainly a consequence of a
decrease in the NTPP/total resonance ratio for three lines. The magnitude of the decrease in the
(PCr + NTPP)/total resonance ratio and the magnitude of the decrease in tumour pH were correlated to the
magnitude of the decrease in blood supply per viable tumour cell. Tumour pH decreased with decreasing
tumour bioenergetic status, and the magnitude of this decrease was larger for the tumour lines showing a high
than for those showing a low blood supply per viable tumour cell.
No correlations across the tumour lines were found between tumour pH and tumour bioenergetic status or
any other resonance ratio on the one hand and blood supply per viable tumour cell on the other. The
differences in the 3IP-NMR spectrum between the tumour lines were probably caused by differences in the
intrinsic biochemical properties of the tumour cells rather than by the differences in blood supply per viable
tumour cell. Biochemical properties of particular importance included rate of respiration, glycolytic capacity
and tolerance to hypoxic stress. On the other hand, tumour bioenergetic status and tumour pH were correlated
to blood supply per viable tumour cell within individual tumour lines. These observations suggest that
31P-NMR spectroscopy may be developed to be a clinically useful method for monitoring tumour blood supply
and parameters related to tumour blood supply during and after physiological intervention and tumour
treatment. However, clinically useful parameters for prediction of tumour treatment resistance caused by
insufficient blood supply can probably not be derived from a single 3'P-NMR spectrum since correlations
across tumour lines were not detected; additional information is needed.
Studies of experimental tumours have suggested that 31P-
NMR spectroscopy may become a useful tool in prediction
and assessment of tumour treatment response (Evanochko et
al., 1984a; Daly & Cohen, 1989; Steen, 1989; Rofstad, 1990).
3"P-NMR spectroscopy has been used to study tumour
metabolism during unperturbed tumour growth (Evanochko
et al., 1982; Ng et al., 1982; Okunieff et al., 1986; Rofstad et
al., 1988b; Koutcher et al., 1990) and to monitor tumour
response to radiation therapy (Sijens et al., 1986; Tozer et al.,
1989; Koutcher et al., 1992), hyperthermia (Lilly et al., 1984;
Sijens et al., 1989; Vaupel et al., 1990), chemotherapy
(Evanochko et al., 1983; Naruse et al., 1985) and photo-
dynamic therapy (Ceckler et al., 1986; Chapman et al., 1991).
These studies have shown that 31P-NMR resonance ratios
may differ considerably among tumour lines (Evanochko et
al., 1982; Ng et al., 1982; Rofstad et al., 1988b) and in
individual tumours before and after therapy (Lilly et al.,
1984; Naruse et al., 1985; Ceckler et al., 1986; Sijens et al.,
1986). It is not yet clear to what extent 3"P-NMR resonance
ratios are governed by intrinsic biochemical properties of the
tumour cells and to what extent they are influenced by the
tumour microenvironment.
However, there is significant evidence that 31P-NMR
tumour energy status; i.e. the PCr/Pi, NTPP/Pi or
(PCr + NTPI)/Pi resonance ratios, is related to tumour blood
flow (Rofstad, 1990; Steen, 1991). Thus, the level of high
energy phosphates in tumours has been shown to decrease
with increasing tumour volume and immediately after hyper-
thermic and photodynamic therapy, due to decreased blood
flow (Okunieff et al., 1986; Vaupel et al., 1990; Chapman et
al., 1991). Radiation therapy and chemotherapy usually
induce an increase in the 3"P-NMR tumour energy status,
consistent with reoxygenation due to increased blood flow
(Rofstad, 1990; Tozer et al., 1989; Steen, 1991). Moreover,
tumour blood flow cessation or reduction induced by clamp-
ing (Bremner et al., 1991), hypovolemic hemoconcentration
(Okunieff et al., 1989), use of systemic vasodilators (Bremner
et al., 1991; Tozer et al., 1990; Okunieff et al., 1988) or
administration of cytokines (Kluge et al., 1992) invariably
leads to decreased 31P-NMR energy status. Only one single or
two different tumour lines were used in most of these studies.
Thus, although the observations suggest that 31P-NMR
tumour energy status is related to blood flow, different rela-
tionships may exist for different lines. In other words, there is
possibly a relationship between 3"P-NMR energy status and
blood flow within tumour lines, but not necessarily across
tumour lines. Consequently, increased understanding of the
potential usefulness of 31P-NMR spectroscopy in prediction
and assessment of tumour treatment response requires studies
relating 31P-NMR energy status to blood flow across tumour
lines.
A 31P-NMR spectroscopy study of six human melanoma
xenograft lines is reported in the present communication. The
xenograft lines were established in our laboratory and have
been characterised with respect to growth and blood flow
(Rofstad et al., 1990; Lyng et al., 1992). The growth and
blood flow characteristics were found to differ considerably
among the lines. The purpose of the study reported here was:
(a) to search for possible differences in 31P-NMR resonance
ratios among tumour lines; and (b) to investigate whether the
differences could be attributed to differences in tumour blood
flow. Tumour lines of the same histological type were chosen
for the study to minimise possible effects of cellular
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differences among the lines, thus increasing the probability of
finding clinically useful correlations across tumour lines.
Blood supply per viable tumour cell was used as parameter
for blood flow because this parameter is of major importance
for the cellular uptake of oxygen and glucose (Lyng et al.,
1992). The spin-lattice relaxation times (Tls) of the seven
major resonances in the 3"P-NMR spectrum have been deter-
mined for the six tumour lines used here (Olsen et al., 1993).
These T,s were used in the present work to correct resonance
ratios for effects of partial saturation.
Materials and methods
Mice and tumour lines
Male BALB/c-nu/nu mice, 8-10 weeks old, were used. They
were bred at the animal department of our institution and
kept under specific-pathogen-free conditions at constant
temperature (24-26°C) and humidity (30-50%). Sterilised
food and tap water were given ad libitum.
The melanoma xenograft lines (BEX-t, COX-t, HUX-t,
ROX-t, SAX-t, WIX-t) were established in athymic mice
from metastases of patients admitted to The Norwegian
Radium Hospital (Rofstad et al., 1990). The ROX-t and
WIX-t tumours contained melanin whereas the tumours of
the other four lines were amelanotic. The lines were main-
tained in the same strain ofmice by serial s.c. transplantation
of tumour fragments, approximately 2 x 2 x 2 mm. Sub-
cutaneous flank tumours in passages 15-25 were used in the
present work. The lines were kinetically stable during the
period while the experiments were carried out, as ascertained
by flow cytometric measurements of DNA histograms and
measurements of volumetric growth rates. Tumours within
the volume range of 100-2,000 mm3 were studied. Tumour
volume was calculated as:
V=/6-ab2 (1)
where a and b are the longer and the shorter of two perpen-
dicular diameters, respectively. Blood flow was measured by
using the 86Rb uptake method (Lyng et al., 1992). Blood
supply per viable tumour cell was calculated by correcting
the data for cell density and fraction of necrotic tumour
tissue. The growth and blood flow characterstics of the lines
have been reported elsewhere (Rofstad et al., 1990; Lyng et
al., 1992). Blood flow parameters of relevance for the present
study are summarised in Table I.
31P-NMR spectroscopy
3'P-NMR spectra were recorded using nonanaesthetised mice
and a Bruker 4.7 T spectrometer operating at 81.025 MHz
for phosphorus. The mice were positioned vertically in the
centre of the magnet bore by means of a perspex jig. A panel
of solenoidal coils featuring appropriate tune and match
capacitors was used for spectral accumulations. A coil fitting
closely around the tumour without compressing it was always
chosen from the panel. A copper foil Faraday shield was
used to eliminate signals from normal tissues adjacent to the
tumour. The homogeneity of the magnetic field was
optimised for each individual tumour by shimming on the
water proton resonance. The acquisition parameters were: 900
pulse angle; 4 KHz spectrum sweep width; 1 K data points
per free induction decay; 2 s repetition time. The number of
acquisitions per spectrum was 900. Spectral processing
included 15-30 Hz exponential multiplication and a convolu-
tion difference of 600 Hz. Peak heights and areas were cal-
culated from the best fits of Lorentzian lineshapes to phased,
resolution-enhanced and baseline-corrected spectra. Relative
peak heights and areas were found to give similar estimates
of relative metabolite concentrations. The data reported here
refer to peak heights. The (PCr + NTPP)/Pi resonance ratio
was used as parameter for 3"P-NMR tumour bioenergetic
status since energy is stored as PCr and ATP in cells and Pi
is the end product when ATP is converted to ADP and
energy. The NTP,B resonance was used as a measure of ATP
because this resonance represents nucleoside triphosphates
alone.
The choice of acquisition parameters was a compromise
between the wishes for high sensitivity, short acquisition time
and almost complete relaxation. The acquisition parameters
did not allow for full relaxation of the spin magnetisation.
The resonance ratios were corrected for effects of partial
saturation using the T,s reported elsewhere (Olsen et al.,
1993) and the relationship:
Mz = Mo0(l e-TR/TI) (2)
where Mz is the longitudinal component of the magnetisa-
tion, Mo is the equilibrium magnetisation and TR is the
acquisition repetition time.
Tumour pH was calculated from the chemical shift of the
Pi peak with reference to the PCr peak using the Henderson-
Hasselbalch equation with pKa = 6.803 (Ng et al., 1982). In a
few spectra the PCr peak was poorly defined, and a reliable
estimate of tumour pH could not be calculated. Tumour pH
measured by 31P-NMR spectroscopy reflects mainly the int-
racellular pH (Tannock & Rotin, 1989).
Spectra of a phosphorus-free gel material implanted s.c. in
the mouse flank were obtained to determine whether signals
from skin and underlying muscle tissue would contribute to
the tumour spectra. No mobile phosphates were detected,
showing that the tumour spectra were not contaminated by
signals from adjacent muscle and skin (Figure la). The
reproducibility of the spectrum acquisition was assessed by
comparing different spectra obtained from the same tumours.
The reproducibility of the spectrum analysis was assessed by
processing and analysing individual spectra several times.
Both reproducibility tests gave entirely satisfactory results
both when resonance ratios and pH were considered (Figure
2).
Statistical analysis
An analysis of variance was applied to investigate whether a
tumour parameter differed significantly among xenograft
lines, and a Student-Newman-Keuls test was applied to iden-
tify the lines that differed from each other (Godfrey, 1985).
Statistically significant correlations between two different
parameters measured for the same lines were searched for by
performing a two-tailed t-test ofcorrelation coefficients deter-
Table I Blood supply per viable tumour cell for human melanoma xenograft lines
Decrease in 86Rb uptake
Melanoma 109 8Rb uptake/viable tumour celP (% ofinjected/cell) per viable tumour cell
xenograft line V = 200 mm' V = S00 mm3 V = 1,000 mm3 with tumour volumeb
BEX-t 1.27±0.13c 1.11 0.06 0.93±0.06 -0.19±0.02
COX-t 4.28 0.44 2.93 0.22 2.17 0.15 -0.42 ± 0.04
HUX-t 4.19 0.30 2.54 0.15 1.82 0.13 -0.52 ± 0.04
ROX-t 2.08 0.27 1.47 0.12 1.14 0.09 - 0.37 ± 0.05
SAX-t 2.83 0.23 2.23 0.16 1.85 0.17 - 0.26 ± 0.02
WIX-t 1.64 ± 0.13 1.22 ± 0.08 0.97 ± 0.09 - 0.33 ± 0.03
aBased on 28-41 tumours. "The slope of linear curves fitted to double logarithmic plots of86Rb uptake per
viable tumour cell (% of injected/cell) vs tumour volume (mm3). CMean ± s.e.31P-NMR SPECTROSCOPY OF MELANOMA XENOGRAFTS 1063
mined by linear regression analysis. A significance level of
P = 0.05 was used throughout.
Results
31P-NMR spectra
Typical 31P-NMR spectra of small SAX-t and WIX-t
tumours are shown in Figure 1. The tumours of all lines
showed qualitatively similar spectra. In some spectra, partic-
ularly from large tumours, no PCr resonance could be seen.
The PME and PDE resonances often appeared as doublets.
The resonance assignment in Figure 1 is in accordance with
results from analyses of perchloric acid tumour extracts
(Evanochko et al., 1984b; Corbett et al., 1987).
Phosphorus-free phantom a
YVJY
is 1o 5 6 -is -io
(ppm)
NTPot
10 5 -5
(ppm)
Wix-t
NTP-y NTP
15 10 5 0 -5
(ppm)
-15 -20
b
-10 -15 -20
aO C
-10 -15 -20
Figure
1 3IP-NMR spectra of a phosphorus-free gel material
implanted s.c. in the flank of a mouse a, a small tumour of the
SAX-t human melanoma xenograft line (V
= 270 mm3) b, and a
small tumour of the WIX-t human melanoma xenograft line
(V
= 180 mm3) c. The spectra in b and c show seven clear, major
peaks corresponding to PME, Pi, PDE, PCr, NTP'y, NTPN and
NTPP. In b the resonance ratios were calculated to be 0.13
(PME/total), 0.18 (Pi/total), 0.06 (PDE/total), 0.09 (PCr/total),
0.16 (NTP-y/total), 0.20 (NTPo/total) and 0.17 (NTPP/total).
Tumour pH was determined to be 7.07. In c the resonance ratios
were calculated to be 0.18 (PME/total), 0.10 (Pi/total), 0.07
(PDE/total), 0.08 (PCr/total), 0.20 (NTPy/total), 0.20 (NTPN/
total) and 0.18 (NTPP/total). Tumour pH was determined to be
7.45.
The PME/total, Pi/total, PDE/total, PCr/total, NTPy/total, NTPN/total, NTPV/total, (PCr + NTPIP)/total and
(PCr + NTPP)/Pi resonance ratios as well as tumour pH were
analysed as a function of tumour volume. The data for one
of the xenograft lines are illustrated in Figure 2. Linear
curves in semilogarithmic diagrams gave good fits to all data
sets. The use of a logarithmic volume axis gave better fits
than the use of a linear volume axis. The parameters defining
the curves in semilogarithmic diagrams are listed in Table II.
The resonance ratios at tumour volumes of 200, 500 and
1,000mm' were determined from the curves and corrected
for effects of partial saturation. The uncorrected and cor-
rected values at 200mm' are listed in Table III. Only minor
differences were found between the two values (Table III)
and the differences were generally even smaller at 500 and
1,000mm' (data not shown). The slopes of uncorrected and
corrected volume-dependence curves were not significantly
different either (data not shown). The standard errors of the
corrected resonance ratios, however, were larger than those
of the uncorrected resonance ratios due to the error compo-
nent associated with the measurement of the T1s (Table III).
The results presented henceforth are therefore based on
uncorrected data. However, no conclusions were drawn
unless they were supported by both uncorrected and cor-
rected data.
Differences among tumour lines
Tumour bioenergetic status; i.e. the (PCr + NTPP)/Pi reson-
ance ratio, was higher for the WIX-t line than for the BEX-t,
COX-t, HUX-t, ROX-t and SAX-t lines (P<0.05), whereas
the latter lines showed only minor differences in bioenergetic
status (Figure 3). The elevated bioenergetic status of the
WIX-t line was due to a low level of inorganic phosphate as
well as a high level of high-energy phosphates; the Pi/total
resonance ratio was reduced at tumour volumes of 200 mm3
and 500 mm3 (P<0.05) (Figure 3a) and the (PCr + NTPP)/
total resonance ratio was enhanced at a tumour volume of
1,000 mm3 (P<0.05) (Figure 3b). Consequently, the (PCr +
NTPP)/Pi resonance ratio was elevated at all tumour volumes
studied (P<0.05) (Figure 3c). The NTP'y/total and NTPN/
total resonance ratios did not differ significantly among the
xenograft lines (Table II).
The BEX-t line showed no change in bioenergetic status
with increasing tumour volume (Table II). Thus, no change
was found in the Pi/total and (PCr + NTPP)/total resonance
ratios either. The other lines showed a significant decrease in
bioenergetic status with increasing tumour volume (P<0.05)
(Table II). The decrease was a consequence of an increase in
the Pi/total resonance ratio (P<0.05, except for the ROX-t
line) as well as a decrease in the (PCr + NTPI3)/total
resonance ratio (P<0.05). The decrease in -the (PCr +
NTPP)/total resonance ratio was either mainly due to a
decrease in the PCr/total resonance ratio (COX-t and HUX-
t) or mainly due to a decrease in the NTPP/total resonance
ratio (ROX-t, SAX-t and WIX-t), depending on the tumour
line (Figure 4). The NTPy/total and NTTPN/total resonance
ratios showed no significant volume-dependence for any of
the xenograft lines (Table II).
The PME/total and PDE/total resonance ratios showed
only minor differences among the xenograft lines and no
significant changes with increasing tumour volume for any line (Table II).
Tumour pH differed among the xenograft lines at small
tumour voluimes, whereas only insignifica-nt differences were
found at large tumour volume-s (Table II). Tumour pH was
higher for the COX-t, HUX-t, ROX-t and WIX-t lines than
for the SAX-t and BEX-t lines at a tumour volume of
500 mm3 (P<0.05) (Figure 3d). The BEX-t line showed a
lower pH at a tumour volume of 200 mm3 than the SAX-t
line (P<0.05). Moreover, the BEX-t line showed no change
in tumour pH with increasing tumour volume, whereas the
other lines showed a significant decrease (P<0.05). The
magnitude of this decrease differed among the lines (Table
II).
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Previous work has shown that tumour pH is related to
bioenergetic status, but different relationships may exist for
different tumour lines (Rofstad et al., 1988d). Linear curves
were fitted to plots of tumour pH vs the (PCr + NTPP)/Pi
resonance ratio. The slopes of the curves differed among the
lines, as illustrated for the BEX-t and COX-t lines in Figure
5. A significant decrease in tumour pH with decreasing
bioenergetic status was found for the COX-t, HUX-t, SAX-t
and WIX-t lines (P<0.05). Tumour pH for the BEX-t and
ROX-t lines was found to be independent of bioenergetic
status.
Relationship to blood supply
The xenograft lines showed considerable differences in
tumour blood supply (Table I). Blood supply per viable
tumour cell decreased with increasing tumour volume for all
lines. The magnitude of the decrease differed among the lines
and was smallest for the BEX-t line. The BEX-t line showed
no statistically significant change in bioenergetic status with
increasing tumour volume. Bioenergetic status decreased with
increasing tumour volume for all the other lines (Table II).
Thus, there was a relationship between bioenergetic status
and blood supply per viable tumour cell within each individ-
ual tumour line. No correlation was found between the
(PCr + NTP,)/Pi resonance ratio or any other resonance
ratio and blood supply per viable tumour cell across the
xenograft lines. However, the magnitude of the decrease in
the (PCr + NTPP)/total resonance ratio was correlated to the
magnitude of the decrease in blood supply per viable tumour
cell; i.e. the volume-dependence of the (PCr + NTPP)/total
resonance ratio was correlated to the volume-dependence of
blood supply per viable tumour cell (P<0.05) (Figure 6a). A
similar trend was observed when the (PCr + NTPP)/Pi
resonance ratio was considered, but a statistically significant
correlation was not found.
Tumour pH did not show a statistically significant change
with increasing tumour volume for the BEX-t line. The other
lines, however, showed a decrease in tumour pH with in-
creasing tumour volume (Table II). Thus, a relationship
between tumour pH and blood supply per viable tumour cell
was found for each individual tumour line. Tumour pH
showed no correlation to blood supply per viable tumour cell
across the xenograft lines. However, a correlation was found
between the magnitude of the decrease in tumour pH and the
magnitude of the decrease in blood supply per viable tumour
cell; i.e. the volume-dependence of tumour pH was correlated
to the volume-dependence of blood supply per viable tumour
cell (P<0.05) (Figure 6b).
The correlation between tumour pH and bioenergetic
status differed between the different xenograft lines (Figure
5). The slope of the linear curves fitted to plots of tumour
pH vs bioenergetic status was positively correlated to blood
supply per viable tumour cell, independent of whether blood
supply per viable tumour cell was measured at tumour
volumes of 200, 500 or 1,000 mm3 (Figure 7). Thus, the
xenograft lines showing a high blood supply per viable
tumour cell (COX-t, HUX-t, SAX-t) showed a large decrease
in tumour pH with decreasing bioenergetic status, whereas
the lines showing the low blood supply per viable tumour cell
(ROX-t, SAX-t, WIX-t) showed only a small or no decrease
in tumour pH with decreasing bioenergetic status.
Discussion
Methodological aspects
The 3"P-NMR spectra of the human melanoma xenografts
studied here were qualitatively similar to those reported for
other human tumour xenografts (Evanochko et al., 1982;
Rofstad et al., 1988b). The tumours showed significant levels
of PCr even at large volumes. It has been suggested that PCr
resonances in tumour spectra are caused by adjacent muscle
tissue or overlying skin rather than by the tumour tissue itself
(Irving et al., 1985). Connective tissue, infiltrating lym-
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Figure 3 Ranges (mean ± s.e.) for Pi/total a, (PCr + NTPP)/total b, (PCr + NTPP)/Pi c, and tumour pH d, vs tumour volume for
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Figure 4 The magnitude of the decrease in PCr/total a, and NTPP/total b, with increasing tumour volume for six human
melanoma xenograft lines (BEX-t, COX-t, HUX-t, ROX-t, SAX-t and WIX-t). Bars: s.e. In a the decrease was statistically
significant for the COX-t (P<0.005) and HUX-t (P<0.0005) lines. In b the decrease was statistically significant for the ROX-t
(P<0.05), SAX-t (P<0.05) and WIX-t (P<0.05) lines.
phocytes and endothelial cells may also contribute to the PCr
resonance. The use of a copper foil Faraday shield and coils
fitting closely around the tumours prevented spectrum con-
tamination by signals from adjacent tissues in the present
work. Thus, "P-NMR spectra of phosphorus-free phantoms
showed no mobile phosphates (Figure la). Moreover, his-
tological analyses have shown that the melanoma xenografts
contain only small amounts of connective tissue, and the
infiltration of lymphocytes is sparse (Rofstad et al., 1990).
The PCr resonance was therefore probably caused mainly by
the melanoma cells themselves.
The 3'P-NMR resonance ratios were corrected for effects
of partial saturation (Table III). Only minor differences were
found between the uncorrected and corrected values. The
WIX-t line showed the largest differences; e.g. the uncor-
rected value for the PME/total resonance ratio was
0.15 ± 0.01 at a tumour volume of 200 mm3, whereas the
corrected value was 0.19 ± 0.01. The differences between the
slopes of uncorrected and corrected curves describing the
volume-dependence of the resonance ratios were also small.
The largest differences were found for the BEX-t line; e.g. the
slopes of the uncorrected and corrected curves for the NTPP/
total resonance ratio were 0.01 ± 0.02 and 0.06 + 0.02,
respectively. The differences in the T,s between resonances
were thus not large enough to cause major differences
between uncorrected and corrected parameters at a repetition
time of 2 s.
The "P-NMR resonance ratios differed considerably
among individual tumours of the same xenograft line even
when tumours were of similar size (Figure 2). Repetitive
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acquisition of spectra from the same tumours and repetitive
analyses of the same spectra showed that the experimental
uncertainties were small (Figure 2), demonstrating that
metabolic differences among individual tumours contributed
significantly to the variability observed. This conclusion is in
agreement with conclusions from studies of the metabolism
of other human tumour xenografts (Kallinowski et al., 1988;
1989).
Biological aspects
The PME/total and PDE/total resonance ratios did not differ
significantly among the xenograft lines. On the other hand,
the xenograft lines showed large differences in tumour
volume-doubling time and fraction of cells in S-phase (Lyng
et al., 1992). Tissue concentrations of phospholipids are
associated with the rate of cell membrane synthesis and
degradation (Miceli et al., 1988; Radda et al., 1989; Van der
Grond et al., 1991). It has been suggested that the PME
and/or PDE resonances of3"P-NMR spectra of tumours may
be utilised to assess the rate of tumour cell proliferation
(Smith et al., 1991; Kalra et al., 1993). The data reported
here does not support this suggestion. However, differences
in volume-doubling time and fraction of cells in S-phase do
not necessarily reflect differences in rate of cell proliferation.
Moreover, a magnetic field strength of 4.7 T may be sup- optimal for the detection of differences in PME and PDE
resonances among tumour lines (Lowry et al., 1992).
The bioenergetic status and the pH of the human
melanoma xenografts were within the same ranges as those
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reported for other experimental human tumours (Rofstad et
al., 1988b; Vaupel et al., 1989a). The BEX-t line showed no
change in bioenergetic status or pH with increasing tumour
volume. The other lines showed a decrease in bioenergetic
status that was accompanied by a decrease in pH (Table II).
Comparable changes in the 3'P-NMR spectrum during
tumour growth have been reported for other transplantable
tumour lines as well (Evanochko et al., 1982; Okunieff et al.,
1986; Rofstad et al., 1988b; Koutcher et al., 1990). The
changes have been attributed to changes in the steady state
tumour cell metabolism occurring when the cellular oxygen
concentration decreases. This is consistent with the observa-
tion that blood supply per viable tumour cell decreased with
increasing tumour volume for the melanoma xenografts
(Table I). Alternatively, it has been suggested that the
changes observed in 3"P-NMR energy parameters during
tumour growth are a consequence ofincreasing occurrence of
acute hypoxia rather than increasing chronic nutrient dep-
rivation (Freyer et al., 1991).
The (PCr + NTPP)/Pi resonance ratio was not correlated
to blood supply per viable tumour cells across the melanoma
xenograft lines. The lack of correlation was probably a con-
sequence of differences in vascular architecture as well as in
cellular biochemistry among the lines. Nutritive blood flow is
not necessarily correlated to total blood flow across tumour
lines, due to differences in capillary branching pattern and
occurrence of arteriovenous anastomoses. There is evidence
that the vascular architecture differed among the melanoma
xenograft lines studied here (Lyng et al., 1992). Nevertheless,
nutritive blood flow was probably correlated to blood supply
per viable tumour cell; a statistically significant correlation
between blood supply per viable tumour cell and fraction of
cells in S-phase has been demonstrated (Lyng et al., 1992).
The differences in bioenergetic status among the lines were
therefore not attributable to differences in nutritive blood
flow alone. The WIX-t line showed significantly higher
bioenergetic status than the other lines in spite of a low
blood supply per viable tumour cell (Figure 3c), possibly
because the WIX-t tumours contained a low fraction of
metabolically active hypoxic cells. This hypothesis is sup-
ported by results from in vitro studies performed in our
laboratory: (a) the WIX-t cells have been found to show
large numbers of mitochondria, high rates of oxygen con-
sumption and poor ability to survive under hypoxic condi-
tions compared with the cells of the other lines; and (b) the
thickness of the viable rim of the WIX-t multicellular
spheroids has been measured to be shorter than the oxygen
diffusion distance. The differences in 3'P-NMR bioenergetic
status observed among the melanoma xenograft lines were
thus possibly caused by differences in intrinsic biochemical
properties of the tumour cells, such as energy demand and
tolerance to hypoxic stress, rather than by the differences in
blood supply per viable tumour cell.
The (PCr + NTP,B)/total resonance ratio and blood supply
per viable tumour cell decreased with increasing tumour
volume. The magnitude of the decrease in high-energy phos-
phates was correlated to the magnitude of the decrease in
blood supply per viable tumour cell (Figure 6a). The
differences in the magnitude of the decrease in high energy
phosphates observed among the melanoma xenograft lines
were therefore probably caused mainly by the differences in
the magnitude of the decrease in tumour blood supply per
viable tumour cell. This conclusion is based on the assum-
ption that the intrinsic biochemical properties of the tumour
cells were maintained within the volume range studied.
The decrease in the (PCr + NTPP)/total resonance ratio
with increasing tumour volume was mainly due to a decrease
in the PCr resonance for the COX-t and HUX-t lines and a
decrease in the NTP,B resonance for the ROX-t, SAX-t and
WIX-t lines (Figure 4). This result can probably be attributed
to physiological heterogeneity within the tumours. Metabolic
compartments with different levels ofhigh-energy phosphates
may exist in tumours due to spatial heterogeneity in blood
supply and oxygenation (Sutherland et al., 1988). Tumour
cells in well perfused compartments can have high levels of
PCr as well as ATP. When the supply of oxygen and glucose
is reduced gradually in such compartments, more and more
cells will utilise their PCr, thus maintaining the level of ATP
while adjusting to new equilibrium states (Tozer & Griffiths,
1992). On the other hand, most cells in poorly perfused
compartments are depleted of PCr. The level of ATP will
therefore decrease in such compartments when the supply of
-oxygen and glucose gradually decreases. The present results
are consistent with the assumption that the decrease in blood
supply with increasing tumour volume occurred mainly in the
first type of compartment for the COX-t and HUX-t lines
and mainly in the second type ofcompartment-for the ROX-
t, SAX-t and WIX-t lines.
Tumour pH differed among the xenograft lines, but the
differences could not be attributed to differences in tumour
blood supply alone; no correlation was found between
tumour pH and blood supply per viable tumour cell across
the lines. The BEX-t and SAX-t lines showed lower pH at
small tumour volumes than the other lines. The low pH of
the BEX-t line was probably a consequence of a low blood
supply per viable tumour cell (Table I). The SAX-t line,
however, also showed low pH in spite of a high blood supply
per viable tumour cell (Table I). Studies in vitro have shown
that the SAX-t cells have high glycolytic capacity compared
with cells of the other lines. Thus, differences in intrinsic
biochemical properties of the tumour cells may have con-
tributed significantly to the differences in tumour pH
observed among the lines.
Tumour pH and blood supply per viable tumour cell
decreased with increasing tumour volume. The magnitude of
the decrease in tumour pH was correlated to the magnitude
of the decrease in blood supply per viable tumour cell
(Figure 6b). The differences in the magnitude of the decrease
in tumour pH observed among the melanoma xenograft lines
were therefore probably caused mainly by the differences in
the magnitude of the decrease in blood supply per viable
tumour cell. This conclusion is based on the assumption that
the glycolytic capacity of the tumour cells showed only minor
changes within the volume range studied.
The magnitude of the decrease in tumour pH with decreas-
ing bioenergetic status was larger for the xenograft lines
showing high than for those showing low blood supply per
viable tumour cell (Figure 7). It is possible that a relatively
large decrease in the blood supply is needed to cause a
decrease in bioenergetic status for the lines showing high
blood supply per viable tumour cell. Tumour pH may thus
decrease considerably because the transport of H+ ions out
of the tumour is reduced. In contrast, a minor decrease in the
blood supply may cause a decrease in bioenergetic status for
the lines showing low blood supply per viable tumour cell.
Consequently, only minor changes in tumour pH may occur.
The 86Rb uptake and 31P-NMR spectroscopy data (Tables
I-III) confirm the validity of the relationships between blood
supply per viable tumour cell and bioenergetic status
assumed here.
Tumour response to radiation therapy, hyperthermia,
chemotherapy and photodynamic therapy depends partly on
physiological conditions in the tumour that are mainly deter-
mined by the tumour blood supply. Tumour 31P-NMR bio-
energetic status was found to be correlated to blood supply
per viable tumour cell within individual melanoma xenograft
lines. This observation is consistent with previous results
showing a relationship between 31P-NMR resonance ratios
and tumour oxygenation. Thus, Evelhoch et al. (1986) found
that the PCr/NTPPand NTPP/Pi resonance ratios were cor-
related to the 15Q perfusion in the well perfused tumour
fraction using a mouse fibrosarcoma line. Similar relation-
ships have been reported between 3"P-NMR resonance ratios
related to tumour energy status and oxygen tension (Okunieff
et al., 1987; Vaupel et al., 1989b; Sostman et al., 1991),
radiobiologic hypoxic fraction (Rofstad et al., 1988a; Wend-
land et al., 1992), and oxyhemoglobin (HbO2) saturation
status (Rofstad et al., 1988a,c). The present results give
further support to the suggestion that 31P-NMR spectroscopy
may be a clinically useful method for monitoring tumour3'P-NMR SPECTROSCOPY OF MELANOMA XENOGRAFTS 1069
blood supply and parameters related to blood supply during
and after physiological intervention and tumour treatment.
It has been suggested that 3"P-NMR resonance ratios may
be used to predict tumour treatment response as well (Ng et
al., 1982; Evanochko et al., 1983; 1984a). However, predic-
tion of treatment response requires correlations between 31P-
NMR resonance ratios and physiological parameters across
tumour lines. Rofstad et al. (1988a) found no correlations
between 3"P-NMR resonance ratios and radiobiologic
hypoxic fraction or HbO2 saturation status across tumour
lines. However, two human ovarian carcinoma and two
murine fibrosarcoma lines were used in their study; i.e. the
tumour lines were of completely different origin. A more
homogeneous tumour panel consisting of six lines of the
same histological type was used in the present study. No
correlations were found between 3'P-NMR resonance ratios
and tumour blood supply across these lines either, indicating
that clinically useful prediction criteria based on 3"P-NMR
resonance ratios may be difficult to find. Consequently, 31p-
NMR resonance ratios probably have to be supplemented
with other data to be useful in prediction of tumour treat-
ment response.
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